Label: NO DRIP SEVERE CONGESTION PREMIER VALUE- oxymetazoline hcl nasal solution spray

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated October 14, 2015

If you are a consumer or patient please visit this version.

  • Active Ingredient

    Oxymetazoline hydrochloride 0.05%

  • Purpose

    Nasal Decongestant

  • Uses

    • Temporarily relieves nasal congestion due to:
      • Common cold
      • Hay fever
      • Upper respiratory allergies
    • Shrinks swollen nasal membranes so you can breathe more freely
  • Warnings

  • Ask a doctor before use if you have

    • heart disease
    • high blood pressure
    • diabetes
    • thyroid disease
    • trouble urinating due to an enlarged prostate gland.
  • When using this product

    • do not use more than directed
    • do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
    • temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge may occur
    • use of this container by more than one person may spread infection
  • Stop use and ask a doctor if

    symptoms persist.

  • If pregnant or breast-feeding,

    ask a health professional before use.

  • Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • Adults and children 6 to 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses within any 24-hour period.
    • Children under 6 years of age: Ask a doctor.

    Shake well before use. Before using for the first time remove the protective cap from the tip and prime metered pump by depressing pump firmly several times. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depress rim with a firm, even stroke and sniff deeply. Wipe nozzle clean after each use.

  • Other Information

    • store between 20°-25°C (68°-77°F)
    • retain carton for future reference on full labeling
  • Inactive Ingredients

    Benzalkonium Chloride, Benzyl Alcohol, Camphor, Edetate Disodium, Eucalyptol, Menthol, Microcrystalline Cellulose, Carboxymethylcellulose Sodium, Polyethylene Glycol, Povidone, Sodium Phosphate Dibasic, Sodium Phosphate Monobasic, Water.

  • Additional information listed on other panels

    SAFETY SEALED: DO NOT USE IF IMPRINTED SEAL ON BOTTLE IS BROKEN OR MISSING.

    *This product is not manufactured or distributed by Procter & Gamble, distributor of Vicks Sinex.

    Distributed By:

    Chain Drug Consortium

    3301 NW Boca Raton Blvd, Suite 101

    Boca Raton, FL 33431

    Made in USA

    If for any reason you are not satisfied with this product, please return it to the store where purchased for a full refund.

  • Principal Display

    *Compare to the active ingredient in Afrin

    Premier Value

    Nasal Decongestant

    No Drip

    ​SEVERE CONGESTION

    ​NASAL SPRAY

    Oxymetazoline HCl Nasal Solution

    12 HOUR PUMP MIST

    Fast, Powerful Congestion Relief

    • Colds 
    • Allergies

    Maximum

    Strength

    plus Menthol

    1 FL OZ (30 mL)

    image description

  • INGREDIENTS AND APPEARANCE
    NO DRIP SEVERE CONGESTION  PREMIER VALUE
    oxymetazoline hcl nasal solution spray
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-309
    Route of AdministrationNASAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OXYMETAZOLINE HYDROCHLORIDE (UNII: K89MJ0S5VY) (OXYMETAZOLINE - UNII:8VLN5B44ZY) OXYMETAZOLINE HYDROCHLORIDE0.05 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    EUCALYPTOL (UNII: RV6J6604TK)  
    MENTHOL (UNII: L7T10EIP3A)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    CARBOXYMETHYLCELLULOSE (UNII: 05JZI7B19X)  
    POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
    POVIDONE (UNII: FZ989GH94E)  
    SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F)  
    SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68016-309-031 in 1 CARTON
    130 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34111/04/2014
    Labeler - Chain Drug Consortium (101668460)
    Registrant - Product Quest Mfg (927768135)
    Establishment
    NameAddressID/FEIBusiness Operations
    Product Quest Mfg927768135manufacture(68016-309)